de Orange Flávia A, Marques Jaime, Flores Marília, Borges Paulo S G N
Teaching and Training Center in Anesthesiology, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, PE, Brazil.
Paediatr Anaesth. 2012 Sep;22(9):890-6. doi: 10.1111/j.1460-9592.2012.03900.x. Epub 2012 Jun 25.
To determine the frequency of postoperative vomiting (POV) in children submitted to outpatient surgery and to compare the efficacy of antiemetic drugs in preventing this complication.
Nausea and vomiting are common in the immediate postoperative period following anesthetic and surgical procedures. Compared to adults, pediatric patients are more likely to develop postoperative nausea and vomiting, the incidence of which ranges from 8.9% to 42%.
This double-blind, randomized, placebo-controlled clinical trial included 129 children. The participants were randomized into three prophylactic treatment groups: dexamethasone (n = 43), ondansetron in combination with dexamethasone (n = 44), and placebo (n = 42). The variables studied were the frequency of POV and the incidence of vomiting after the patient had been discharged from hospital, the need for antiemetic rescue therapy in the postanesthesia care unit (PACU), need for hospitalization, and the time the patient remained in the PACU. A significance level of 5% was adopted.
Postoperative vomiting occurred in 12.4% of the children, with no statistically significant difference between the groups: 6.8% in the group receiving ondansetron combined with dexamethasone, 14.3% in the placebo group, and 14% in the group that received dexamethasone alone (P = 0.47). Furthermore, no significant difference was found between the groups with respect to the time the children remained in the PACU, and only five patients reported having vomited following discharge from hospital.
The prophylactic use of antiemetic drugs failed to reduce the incidence of POV in pediatric outpatient surgery with a low emetic potential; therefore, routine prophylaxis may be unnecessary.
确定接受门诊手术的儿童术后呕吐(POV)的发生率,并比较止吐药物预防这种并发症的疗效。
恶心和呕吐在麻醉和外科手术后的即刻术后阶段很常见。与成人相比,儿科患者更易发生术后恶心和呕吐,其发生率在8.9%至42%之间。
这项双盲、随机、安慰剂对照临床试验纳入了129名儿童。参与者被随机分为三个预防性治疗组:地塞米松组(n = 43)、昂丹司琼联合地塞米松组(n = 44)和安慰剂组(n = 42)。研究的变量包括POV的发生率、患者出院后呕吐的发生率、在麻醉后护理单元(PACU)需要止吐抢救治疗的情况、需要住院的情况以及患者在PACU停留的时间。采用5%的显著性水平。
12.4%的儿童发生了术后呕吐,各组之间无统计学显著差异:昂丹司琼联合地塞米松组为6.8%,安慰剂组为14.3%,单独接受地塞米松组为14%(P = 0.47)。此外,各组在儿童在PACU停留的时间方面无显著差异,只有五名患者报告出院后呕吐。
在呕吐风险较低的儿科门诊手术中,预防性使用止吐药物未能降低POV的发生率;因此,常规预防可能没有必要。